Synthesis and Biological Activity of Unsymmetrical Monoterpenylhetaryl Disulfides.

New unsymmetrical monoterpenylhetaryl disulfides based on heterocyclic disulfides and monoterpene thiols were synthesized for the first time in 48-88% yields. Hydrolysis of disulfides with fragments of methyl esters of 2-mercaptonicotinic acid was carried out in 73-95% yields. The obtained compounds were evaluated for antioxidant, antibacterial, antifungal activity, cytotoxicity and mutagenicity.

Correction: Novel cationic 1,2,4-selenadiazoles: synthesis addition of 2-pyridylselenyl halides to unactivated nitriles, structures and four-center Se⋯N contacts.

Correction for 'Novel cationic 1,2,4-selenadiazoles: synthesis addition of 2-pyridylselenyl halides to unactivated nitriles, structures and four-center Se⋯N contacts' by Victor N. Khrustalev , , 2021, , 10689-10691, DOI: 10.1039/D1DT01322J.

Novel cationic 1,2,4-selenadiazoles: synthesis via addition of 2-pyridylselenyl halides to unactivated nitriles, structures and four-center SeN contacts.

2-Pyridylselenyl halides undergo facile coupling with a triple CN bond of unactivated nitriles. Unprecedented heterocyclization allowed the preparation of a novel class of cationic 1,2,4-selenadiazoles in remarkably high yields. Cationic 1,2,4-selenadiazoles form supramolecular dimers in the crystal via SeN chalcogen bonding, which was studied theoretically.

Bromination of bis-(pyridin-2-yl) diselenide in methyl-ene chloride: the reaction mechanism and crystal structures of 1-pyridine-2-selenenyl dibromide and its cyclo-adduct with cyclo-pentene (3a,9a)-2,3,3a,9a-tetra-hydro-1-cyclo-penta-[4,5][1,3]selenazolo[3,2-]pyridinium bromide.

1-Pyridine-2-selenenyl dibromide, CHNSeBr, , is a product of the bromination of bis-(pyridin-2-yl) diselenide in methyl-ene chloride recrystallization from methanol. Compound is essentially zwitterionic: the negative charge resides on the SeBr moiety and the positive charge is delocalized over the pyridinium fragment. The C-Se distance of 1.

Crystal structure of rac-(3aR*,9aS*)-4,4,4-tri-chloro-1,2,3,3a,4,9a-hexa-hydro-4λ(5),9λ(4)-cyclo-penta-[4,5][1,3]tellurazolo[3,2-a]pyridine.

The title compound, C10H12Cl3NTe, crystallizes with two crystallographically independent mol-ecules (A and B) in the asymmetric unit. In each case, the coordination around the Te atom is distorted square-pyramidal, with the equatorial plane composed of the three Cl atoms and the C atom of the pyridinium ring. The Te atom is displaced from the mean-square plane by 0.